Catalyst Pharmaceuticals, Inc. (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

23.23

-0.16 (-0.68%)

At close: Mar 13, 2026, 4:00 PM EDT

23.71

+0.48 (2.07%)

After-hours: Mar 13, 2026, 7:45 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development and Commercialization of Drug Products	588.99M	491.73M	398.20M	214.20M	140.83M
Development and Commercialization of Drug Products Growth	19.78%	23.49%	85.90%	52.10%	18.27%
Total	588.99M	491.73M	398.20M	214.20M	140.83M
Total Growth	19.78%	23.49%	85.90%	52.10%	18.27%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	588.99M	491.73M	398.20M	214.20M	140.83M
United States Growth	19.78%	23.49%	85.90%	52.10%	18.27%
Total	588.99M	491.73M	398.20M	214.20M	140.83M
Total Growth	19.78%	23.49%	85.90%	52.10%	18.27%

Source: S&P Global Market Intelligence.